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Abstract 
Background: There is a limited knowledge on use of drugs during pregnancy including beneficial 
and possible adverse effects of drugs on both the mother and the fetus. 
Objective: To investigate epidemiology of use of drugs during pregnancy. 
Methods: A cross sectional hospital based study at Medani Hospital during the period December 
2011. After signing an informed consent, a pre-tested questionnaire was used to gather data from 
each parturient mother on her age, parity, level of education, antenatal care visits and use of drug 
during the index pregnancy.  
Results: The vast majority (334; 98.2%) of the interviewed women used drugs during the index 
pregnancy. Around ten percent (35; 10.5%) of these women used the drugs in the first trimester of 
pregnancy. The majority (266; 78.2%) used the drugs in third trimester and the rest used it in the 
second trimester. The most common drugs used were antibiotics, tonics, antimalarials and 
antiemetic. 
Conclusion: There is a very high rate of drug use in this setting. Antibiotics and antimalarials drugs 
were the most used drugs.  
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ost women use prescribed drugs 
during pregnancy from categories 
C, D, or X of the United States 
Food and Drug Administration risk 
classification system, therefore this highlights 
the importance of the need to understand the 
effects of these medications on the developing 
fetus and on the pregnant woman1, 2.There is a 
limited knowledge on use of drugs during 
pregnancy including beneficial andpossible 
adverse effects of drugs on both the mother 
and the fetus.  The vast majority of thedata on 
drug exposure during pregnancy are from 
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the developing countries where the 
pharmacovigilance and drug registry systems 
are in place3, 4. This is not the case in 
developing countries where the assessment of 
drug exposure in pregnancy is complicated by 
high parity and clinical complaints ofseveral 
endemic diseases such as malaria and 
schistosomiasis where it is difficult to dissect 
the disease and the drug adverse effects5-7.
Furthermore in countries with less resource, 
recording of drug exposure during pregnancy 
is inadequate. In most of the developing 
countries there is no baseline data on birth 
outcomes that can be used in 
assessmentregarding the effect of these drugs. 
In sub-Saharan which is endemic for 
communicable diseases   anti-infectivedrugs 
are often used during pregnancy, and thus 
they should always be considered in any drug 
exposure assessment in these areas8-10. The 
situation may be different where drugs used 
for chronic diseases are likely to be used by 
pregnant women in developed countries. The 
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current study was conducted at Medani 
Maternity Hospital in Central Sudan to 
investigate incidence and type of drugs used 
during pregnancy.  
Methods: 
This is an observational cross-sectional study 
conducted at Medani Maternity Hospital in 
Central Sudan during December 2011.  
Medani Maternity Hospital is a tertiary care 
hospital for those women who had antenatal 
care at the hospital and for those who 
werereferred from the other clinics and 
hospitals. Women with risk factors or 
obstetric/medical complications are referred 
to the hospital. However many women 
without any significant complications are 
allowed to deliver at the hospital. After 
signing an informed consent, a medical 
officer used a pre-tested questionnaire in the 
local language (Arabic) to gather data from 
each parturient mother on her age, parity, 
level of education, antenatal care visits and 
use of drugs during the index pregnancy.Then 
the detailed information on the drugs that 
were used in pregnancy including type, time 
of the drug use and the prescriber were taken.  
Thenadditional information was obtained 
through revision of antenatal and admission 
files and drug prescriptions when available. 
Ethics 
The data in the files of the patients were 
analyzed anonymously and no personal data 
were required. The study was approved by the 
local ethical board of the institution.
Results:  
The characteristic of these women enrolled in 
the study were shown in table 1.  Out of these 
340 interviewed women, 93 (27.4%) and 136 
(40%) women were illiterate and of rural 
residence, respectively. The vastmajority  
Table 1: The characteristics of the women 









Gravidity 2.9 (2.0) [1-10.0] 
Parity 1.8 (1.9) [0-9] 
(334; 98.2%) of the interviewed women used 
drugs during the index pregnancy. Around ten 
percent (35; 10.5%) of these women used the 
drugs in the first trimester (the first 13 weeks) 
of pregnancy.The majority (266; 78.2%) used 
the drugs in third trimester (more than 28 
weeks), and the rest used it in the second 
trimester (14-28 weeks).  
The most common drugs used were 
antibiotics, tonics, antimalarials and 
antiemetic, (table 2). The mean (SD) of the 
number of drugs used per woman was 2.9 
(1.6). One woman used nine drugs during her 
index pregnancy.Few (10; 3.0%) women took 
drugs by themselves, 16 (4.7%) women 
received the drugs from nurses and the 
doctors prescribed drugs for the majority 
(308; 92.2%) of the women.  
Discussion: 
The main finding of the current study was the 
high rate of drugs used during pregnancy and 
the most used drugs were antibiotics and 
antimalarials.Interestingly in our previous 
report, out of 33 women who had significant 
bacteriuria, 14 (42.2%) received antibiotic in 
the index pregnancy11. Recently it has been 
shown that 41% (1276/3105) of participants 
in Mozambique reported at least one drug 
exposure during pregnancy9. In Nigeria, 
11.2% of all prescribed drugs in pregnancy 
were antimalarials, representing the third 
most prescribed drug class in this 
group10.Antimalarials drug combinations that 
include artemisinin derivatives (artemisinin-
based combination therapy; ACTs) are now 
recommended for treatment in most malaria 
endemic areas12. This recommendation 
includes pregnant women (except during the 
first trimester). Therefore, there is still very 
little information on the safety of these 
drugcombinations in pregnancy in this early 
period of pregnancy8.
In the current study ten percent (35; 10.5%) of 
these women used the drugs in the first 
trimester of pregnancy. Time of exposure to 
the drugs during pregnancy is of importance 
because the period of teratogenesis may be 
quite short. However, studies investigated 
these drugs during pregnancy were based on 
linkage with registers that might be uncertain.  
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Table 2: drugs used by the pregnant women at 
Medani Hospital, Sudan (n= 340). 
This might not be the case for drugs used for 
chronic illness compared with occasionally 
used drugs like antibiotics and sedatives13.
Generally, a teratogen does not uniformly 
increase the rates of all malformations, but 
rather tends to increase rates of selected 
malformations14.
As mentioned above there should be a balance 
between the risks of the disease itself and the 
drugs used to treat that disease. On the other 
hand it is sometimes difficult to differentiate 
whether the adverse pregnancy outcome is 
related to the disease or the drug used to treat 
that disease.  Hypertension is the most 
common medical complication of pregnancy 
and it has serious sequelae during 
pregnancy.The benefits of drugs (e.g. beta 
blockers) used extend to both the mother and 
the infant, and serve to reduce the morbidity 
that would otherwise result from uncontrolled 
hypertension.However, these drugs (beta 
blockers) are not free of adverse effects on 
unborn babies15.
It worth mentioning that recent studies 
showed that even drugs that seemingly and 
obviously free of adverse effects on 
pregnancy outcomes such as analgesics and 
antibiotics have adverse effects on the mother 
and the baby16, 17.
Conclusion: 
In conclusion, we found that a large 
proportion of women in this setting used 
drugs during pregnancy and the most of these 
used drugs were antibiotics and antimalarials.
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